Microbiological diagnosis of pulmonary invasive aspergillosis in critically ill patients with severe SARS-CoV-2 pneumonia: a bronchoalveolar study

Á Estella, I Martín-Loeches, MR Núñez… - Annals of clinical …, 2023 - Springer
Background Diagnosing COVID-19-associated pulmonary aspergillosis (CAPA) can be
challenging since radiological and clinical criteria in the critically ill patient are nonspecific …

Incidence and risk factors of COVID-19-associated pulmonary aspergillosis in intensive care unit—a monocentric retrospective observational study

E Gregoire, BF Pirotte, F Moerman, A Altdorfer… - Pathogens, 2021 - mdpi.com
Coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) is an
increasingly recognized complication of COVID-19 and is associated with significant over …

COVID-19-associated pulmonary aspergillosis (CAPA)

G Dimopoulos, MP Almyroudi… - Journal of Intensive …, 2021 - mednexus.org
Invasive Pulmonary Aspergillosis (IPA) has been recognized as a possible secondary
infection complicating Coronavirus disease 2019 (COVID-19) and increasing mortality. The …

Epidemiology of invasive pulmonary aspergillosis among intubated patients with COVID-19: a prospective study

M Bartoletti, R Pascale, M Cricca… - Clinical Infectious …, 2021 - academic.oup.com
Background We evaluated the incidence of invasive pulmonary aspergillosis among
intubated patients with critical COVID-19 and evaluated different case definitions of invasive …

Prospective and systematic screening for invasive aspergillosis in the ICU during the COVID-19 pandemic, a proof of principle for future pandemics

R van Grootveld, J van Paassen, ECJ Claas… - Medical …, 2024 - academic.oup.com
The diagnostic performance of a prospective, systematic screening strategy for COVID-19
associated pulmonary aspergillosis (CAPA) during the COVID-19 pandemic was …

Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis

PE Verweij, RJM Brüggemann, E Azoulay… - Intensive care …, 2021 - Springer
Purpose Invasive pulmonary aspergillosis (IPA) is increasingly reported in patients with
severe coronavirus disease 2019 (COVID-19) admitted to the intensive care unit (ICU) …

Risk factors and the value of microbiological examinations of COVID-19 associated pulmonary aspergillosis in critically ill patients in intensive care unit: the …

X Zhou, X Wu, Z Chen, X Cui, Y Cai, Y Liu… - Frontiers in Cellular …, 2023 - frontiersin.org
Introduction During the Omicron pandemic in China, a significant proportion of patients with
Coronavirus Disease 2019 (COVID-19) associated pulmonary aspergillosis (CAPA) …

Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: Results from the prospective AspCOVID-19 study

T Lahmer, S Kriescher, A Herner, K Rothe, CD Spinner… - PloS one, 2021 - journals.plos.org
Background Superinfections, including invasive pulmonary aspergillosis (IPA), are well-
known complications of critically ill patients with severe viral pneumonia. Aim of this study …

A Tale of Two Hospitals: Comparing CAPA Infections in Two ICUs During the Spanish Fourth Pandemic Wave

MÁ Sánchez-Castellano, C Marcelo, J Marco… - Mycopathologia, 2023 - Springer
Purpose COVID-19 associated pulmonary aspergillosis (CAPA) is a new clinical entity
linked to SARS-CoV-2 infection that is causing a rise on the risk of complications and …

Lateral flow assay (LFA) in the diagnosis of COVID-19-associated pulmonary aspergillosis (CAPA): a single-center experience

I Serin, S Baltali, TA Cinli, H Goze, B Demir… - BMC Infectious …, 2022 - Springer
Background Invasive pulmonary aspergillosis (IPA) is seen during coronavirus-2019
(COVID-19), has been reported in different incidences, and is defined as COVID-19 …